Comprehensive results, fewer appointments
Patient-Centric Diagnostics
Minimally Invasive Precision
Austpath evaluates samples immediately at the bedside to ensure adequacy, avoiding unnecessary repeat biopsies. This minimizes discomfort and enables provisional diagnosis when it matters most.
Trusted Diagnostic Partner
Discover why Austpath Laboratories is the trusted choice by most endocrinologists for accurate and efficient diagnostic procedures.
Experience You Can Trust
With over 40 years of diagnostic experience and global training, Dr Edward Chandraratnam brings unparalleled expertise to every biopsy performed at Austpath.
Comparatively Lower Biopsies
Most FNAs typically make three passes to ensure adequate material is obtained as they do not have access to ROSE.
ROSE allows on-the-spot confirmation, avoiding unnecessary biopsies.
All in One Appointment
ROSE streamlines the diagnostic process by ensuring all necessary samples are ideally collected in a single visit—even when multiple nodules are present.
No Unecessary Passes or Biopsies
By confirming sample adequacy on the spot, ROSE prevents repeated needle passes —making the procedure safer, quicker, and more comfortable for patients.
Immediate Bedside Assessment
With ROSE the sample is immediately assessed at the bedside, so if there is sufficient tissue on the first pass, there is no need for a repeat biopsy.
Rapid
On-Site
Evaluation
What is ROSE?
Rapid On-Site Evaluation (ROSE) is a crucial step in FNA cytology where the sample is immediately assessed at the bedside.
